Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

2.39

Today's Change

+0.06 (2.57%)

Day's Change

2.32 - 2.44

Trading Volume

3,124,961

Overview

Market Cap

863 Million

Shares Outstanding

361 Million

Avg Volume

2,801,132

Avg Price (50 Days)

1.82

Avg Price (200 Days)

1.74

PE Ratio

-2.88

EPS

-0.83

Earnings Announcement

01-Aug-2024

Previous Close

2.33

Open

2.43

Day's Range

2.32 - 2.44

Year Range

0.92 - 3.73

Trading Volume

3,124,961

Price Change Highlight

1 Day Change

2.58%

5 Day Change

13.27%

1 Month Change

42.26%

3 Month Change

51.27%

6 Month Change

31.32%

Ytd Change

50.31%

1 Year Change

23.20%

3 Year Change

-29.50%

5 Year Change

-58.00%

10 Year Change

-76.29%

Max Change

-98.18%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment